TY  - JOUR
T1  - An Overview of Chronic Obstructive Pulmonary Disease “COPD” Diagnosis and Management
A1  - Osama M. M. Alanazi
A1  - Abdulmajeed S. O. Alanazi
A1  - Mohammed K. D. Al-Shakarh
A1  - Ghadeer A. H. Alaliwat
A1  - Yahya A. M. Adawi
A1  - Sultan M. H. Alanazi
A1  - Mashael R. M. Alshammari
A1  - Hadi A. Alshehri
A1  - Salihah Y. Al-Mani
A1  - Khalil N. Abujabr
A1  - Reem H. Mohammed
JF  - Pharmacophore
JO  - Pharmacophore
SN  - 2229-5402
Y1  - 2020
VL  - 11
IS  - 4
SP  - 150
EP  - 153
N2  - Background: Chronic obstructive pulmonary disease (COPD) is a critical form of slowly progressive pathological changes that occurs in the pulmonary system resulting in the central and peripheral airway and parenchymal destruction. In 2015, chronic obstructive pulmonary diseases are known to be the cause of more than 3 million (5%) deaths around the world. By the end of 2020, it is postulated that COPD would be the third most killing disease in the world. The chronic obstructive pulmonary disease has often received little attention worldwide and often is usually underdiagnosed. Past medical history, family history, and physical examination are the core stone of diagnosis for COPD patients. Objective: To assist physicians’ approach towards COPD by defining the epidemiological importance of the disease, pathogenesis, clinical expression, and up to date therapeutic modalities. Methodology: This review is based on various updated and published data that were collected from PubMed websites. Multiple journals, articles, and documents on this engine were searched. Conclusion: Physicians must determine and understand COPD GOLD assessment strategies to adopt appropriate inpatient and outpatient management plan for the patient.
UR  - https://pharmacophorejournal.com/article/an-overview-of-chronic-obstructive-pulmonary-disease-copd-diagnosis-and-management
ER  -